References
- Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57–65.
- Meienberg O. Lesion site in Fisher’s syndrome. Arch Neurol 1984;41:250–251.
- al-Din SN, Anderson M, Eeg-Olofsson O, Trontelj JV. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review. Acta Neurol Scand 1994;89:157–163.
- Ropper AH, Shahani B. Proposed mechanism of ataxia in Fisher’s syndrome. Arch Neurol 1983;40:397–398.
- Aranyi Z, Covacs T, Sipos I, Bereczki D. Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur J Neurol 2010;19:15–20.
- Toru S, Ohara M, Hane Y, Ishiguro T, Kobayashi T. Successful steroid treatment for recurrent miller fisher syndrome. Muscle Nerve 2012;5:763–764.
- Scoppetta C, Fontana M, Quadrini RI, La Cesa I, Di Lello R, Peppe A, Tolli VS Casali C. Miller Fisher syndrome: review of the literature and presentation of 2 cases. Riv Neurol 1991;61:137–144.
- Grosso S, Verrotti A, Tei M, Cornecchione S, Giannini F, Balestri P. Recurrent Miller Fisher syndrome in children. Pediatr Neurol 2014;50:269–271.
- Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992,31:677–679.
- Susuki K, Yuki N, Muramatsu M, Hirata K. Unilateral ophthalmoparesis and limb ataxia associated with anti-GQ1b IgG antibody. J Neurol 2000;247:652–653.
- Yuki N, Odaka M, Hirata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology 2001;108:196–200.